Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)

The standard of care for advanced non-small cell lung cancer (NSCLC) without known driver oncogenes is immune checkpoint inhibitor (ICI) therapy combined with platinum-based chemotherapy. About 20% of patients with advanced NSCLC have brain metastases, which are related to poor prognosis. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya-Kawano, Yuko, Shiraishi, Yoshimasa, Kiyomi, Fumiaki, Okamoto, Isamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593342/
https://www.ncbi.nlm.nih.gov/pubmed/34795528
http://dx.doi.org/10.2147/CMAR.S341287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593342/
https://www.ncbi.nlm.nih.gov/pubmed/34795528
http://dx.doi.org/10.2147/CMAR.S341287

Ejemplares similares